Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Goldgar

Showing results (21-30 of 75) with videos related to

Pageof 8
Sort By:
Breast Cancer Research and Treatment|September 29, 2007
G1738R is a BRCA1 founder mutation in Greek breast/ovarian cancer patients: evaluation of its pathogenicity and inferences on its genealogical historyTheodore Anagnostopoulos, Maroulio Pertesi, Irene Konstantopoulou, et al.
Breast Cancer Research and Treatment|May 16, 2015
Second primary breast cancer in BRCA1 and BRCA2 mutation carriers: 10-year cumulative incidence in the Breast Cancer Family RegistryTehillah S Menes, Mary Beth Terry, David Goldgar, et al.
Human Mutation|August 31, 2002
Analysis of breast cancer susceptibility genes BRCA1 and BRCA2 in Thai familial and isolated early-onset breast and ovarian cancerPimpicha Patmasiriwat, Kris Bhothisuwan, Olga M Sinilnikova, et al.
Journal of Medical Genetics|November 5, 2015
Targeted massively parallel sequencing of a panel of putative breast cancer susceptibility genes in a large cohort of multiple-case breast and ovarian cancer familiesJun Li, Huong Meeks, Bing-Jian Feng, et al.
Human Genetics|May 11, 2005
Molecular and genealogical characterization of the R1443X BRCA1 mutation in high-risk French-Canadian breast/ovarian cancer familiesHélène Vézina, Francine Durocher, Martine Dumont, et al.
Genetic Testing|June 24, 2006
No Evidence of BRCA1/2 genomic rearrangements in high-risk French-Canadian breast/ovarian cancer familiesAnne-Marie Moisan, Jessyka Fortin, Martine Dumont, et al.
Human Mutation|March 26, 2003
Haplotype analysis of the BRCA2 9254delATCAT recurrent mutation in breast/ovarian cancer families from SpainBerta Campos, Orland Díez, Fabrice Odefrey, et al.
BMC Genomics|September 1, 2007
Genomewide high-density SNP linkage analysis of non-BRCA1/2 breast cancer families identifies various candidate regions and has greater power than microsatellite studiesAnna Gonzalez-Neira, Juan Manuel Rosa-Rosa, Ana Osorio, et al.
Breast Cancer Research and Treatment|August 26, 2017
Panel sequencing of 264 candidate susceptibility genes and segregation analysis in a cohort of non-BRCA1, non-BRCA2 breast cancer familiesJun Li, Hongyan Li, Igor Makunin, et al.
Genes, Chromosomes & Cancer|September 27, 2006
Characterization of the breast cancer associated ATM 7271T>G (V2424G) mutation by gene expression profilingNic Waddell, Jyoti Jonnalagadda, Anna Marsh, et al.
Pageof 8

Showing results (21-30 of 75) with videos related to

Sort By:
Pageof 8
Breast Cancer Research and Treatment|September 29, 2007
G1738R is a BRCA1 founder mutation in Greek breast/ovarian cancer patients: evaluation of its pathogenicity and inferences on its genealogical historyTheodore Anagnostopoulos, Maroulio Pertesi, Irene Konstantopoulou, et al.
Breast Cancer Research and Treatment|May 16, 2015
Second primary breast cancer in BRCA1 and BRCA2 mutation carriers: 10-year cumulative incidence in the Breast Cancer Family RegistryTehillah S Menes, Mary Beth Terry, David Goldgar, et al.
Human Mutation|August 31, 2002
Analysis of breast cancer susceptibility genes BRCA1 and BRCA2 in Thai familial and isolated early-onset breast and ovarian cancerPimpicha Patmasiriwat, Kris Bhothisuwan, Olga M Sinilnikova, et al.
Journal of Medical Genetics|November 5, 2015
Targeted massively parallel sequencing of a panel of putative breast cancer susceptibility genes in a large cohort of multiple-case breast and ovarian cancer familiesJun Li, Huong Meeks, Bing-Jian Feng, et al.
Human Genetics|May 11, 2005
Molecular and genealogical characterization of the R1443X BRCA1 mutation in high-risk French-Canadian breast/ovarian cancer familiesHélène Vézina, Francine Durocher, Martine Dumont, et al.
Genetic Testing|June 24, 2006
No Evidence of BRCA1/2 genomic rearrangements in high-risk French-Canadian breast/ovarian cancer familiesAnne-Marie Moisan, Jessyka Fortin, Martine Dumont, et al.
Human Mutation|March 26, 2003
Haplotype analysis of the BRCA2 9254delATCAT recurrent mutation in breast/ovarian cancer families from SpainBerta Campos, Orland Díez, Fabrice Odefrey, et al.
BMC Genomics|September 1, 2007
Genomewide high-density SNP linkage analysis of non-BRCA1/2 breast cancer families identifies various candidate regions and has greater power than microsatellite studiesAnna Gonzalez-Neira, Juan Manuel Rosa-Rosa, Ana Osorio, et al.
Breast Cancer Research and Treatment|August 26, 2017
Panel sequencing of 264 candidate susceptibility genes and segregation analysis in a cohort of non-BRCA1, non-BRCA2 breast cancer familiesJun Li, Hongyan Li, Igor Makunin, et al.
Genes, Chromosomes & Cancer|September 27, 2006
Characterization of the breast cancer associated ATM 7271T>G (V2424G) mutation by gene expression profilingNic Waddell, Jyoti Jonnalagadda, Anna Marsh, et al.
Pageof 8